Curtis JR, Elewaut D, Chen S, Hojnik M, Naveh N, Anderson JK. Incidence of Inflammatory Bowel Disease Events in Adalimumab Clinical Trials Across Indications. J of Skin [Internet]. 2017 Oct. 27 [cited 2024 Jul. 4];1(3.1):s18. Available from: https://jofskin.org/33014/index.php/skin/article/view/73